Page last updated: 2024-08-24

edda and gastrins

edda has been researched along with gastrins in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Decristoforo, C; Dietrich, H; Gabriel, M; Skvortsova, I; Virgolini, IJ; von Guggenberg, E1
Czepczyński, R; Gryczyńska, M; Kosowicz, J; Mikołajczak, R; Sowiński, J; Ziemnicka, K1

Trials

1 trial(s) available for edda and gastrins

ArticleYear
Two peptide receptor ligands (99m)Tc-EDDA/HYNIC-Tyr(3)-octreotide and (99m)Tc-EDDA/HYNIC-(D)Glu-octagastrin for scintigraphy of medullary thyroid carcinoma.
    Cancer biotherapy & radiopharmaceuticals, 2007, Volume: 22, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Animals; Carcinoma, Medullary; Edetic Acid; Female; Gastrins; Humans; Hydrazines; Indium Radioisotopes; Male; Mice; Mice, Inbred BALB C; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Nicotinic Acids; Organotechnetium Compounds; Radionuclide Imaging; Sensitivity and Specificity; Thyroid Gland; Thyroid Neoplasms

2007

Other Studies

1 other study(ies) available for edda and gastrins

ArticleYear
99mTc-labelled HYNIC-minigastrin with reduced kidney uptake for targeting of CCK-2 receptor-positive tumours.
    European journal of nuclear medicine and molecular imaging, 2007, Volume: 34, Issue:8

    Topics: Animals; Carcinoma, Medullary; Cysteine; Edetic Acid; Gastrins; Gene Expression Regulation, Neoplastic; Glycine; Humans; Kidney; Liver; Neoplasms; Organotechnetium Compounds; Radionuclide Imaging; Rats; Receptor, Cholecystokinin B; Technetium; Thyroid Neoplasms; Tissue Distribution

2007